Research and Scholarship
Shared Decision-Making in Managing Breakthrough Cancer Pain in Patients With Advanced Cancer
Jeannine M. Brant,(1) PhD, APRN, AOCN®, FAAN, Debra Wujcik,(2) PhD, RN, FAAN, William N. Dudley,(3) PhD, Alison Petok,(4) MSW, LSW, Brooke Worster,(4) MD, Diane Jones,(1) MSN, NP, Kim Bosket,(1) RN, BSN, OCN®, Christian Brady,(1) MSN, AGNP, APRN, and Carrie Tompkins Stricker,(4) PhD, RN, ANP-BC
From (1)Billings Clinic, Billings, Montana; (2)Carevive Systems, Inc., Nashville, Tennessee; (3)Piedmont, Greensboro, North Carolina; (4)Thomas Jefferson University, Philadelphia, Pennsylvania
Authors’ disclosures of conflicts of interest are found at the end of this article.
Correspondence to: Jeannine M. Brant, PhD, APRN, AOCN®, FAAN, Billings Clinic, 2800 10th Avenue North, Billings, MT 59102.
J Adv Pract Oncol 2022;13(1):19–29 |
© 2022 Harborside™
Background: Pain is a significant problem in patients with cancer. Breakthrough cancer pain contributes to the pain experience, but it is often underassessed and underrecognized. Shared decision-making (SDM), where patient preferences, goals, and concerns are discussed and integrated into a shared decision, can potentially foster earlier identification of pain, including breakthrough cancer pain, and improve pain management. Objectives: To explore the use of SDM to evaluate its impact on cancer pain management. Methods: This prospective, multisite study engaged patients with advanced cancer to explore the use of SDM in managing cancer pain using a digital platform with an expanded pain assessment. Decision preferences were noted and incorporated into care. Outcomes included pain and patient-perceived pain care quality. Results: 51 patients with advanced cancer enrolled in the study. The mean pain score was 5 out of 10 throughout the three study time points. 88% of patients experienced breakthrough cancer pain of severe intensity at baseline and approximately 70% at visits two and three. The majority of breakthrough cancer pain episodes lasted longer than 30 minutes. The majority (86%) of participating patients desired shared decision-making or patient-driven decision-making. Most patients expressed satisfaction with the level of shared decision-making in managing their cancer pain. Breakthrough cancer pain remained significant for most patients. Conclusions: SDM incorporated into pain discussions has the potential to improve pain outcomes, but significant challenges remain in managing breakthrough cancer pain.
For access to the full length article, please sign in